Understanding How Ninlaro Works in the Treatment of Multiple Myeloma
Ninlaro, an innovative oral proteasome inhibitor, plays a crucial role in the treatment of multiple myeloma, especially for patients with prior therapies. Approved by the FDA, it forms part of a triplet therapy that significantly extends progression-free survival. Explore its mechanism, clinical efficacy, side effects, and the convenience it offers to enhance patient quality of […]
3 minute read